Aratana Theraptcs
(PETX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Sales | 10,457 | 6,163 | 5,158 | 3,795 | 292 |
| Cost of Goods | 5,912 | 3,690 | 3,691 | 3,094 | 1,093 |
| Gross Profit | 4,545 | 2,473 | 1,467 | 701 | -801 |
| Operating Expenses | 20,305 | 11,346 | 11,748 | 12,630 | 22,197 |
| Operating Income | -14,848 | -8,183 | -9,590 | -11,835 | -22,905 |
| Interest Expense | 880 | 870 | 871 | 860 | 842 |
| Other Income | 130 | 133 | 81 | 83 | 414 |
| Pre-tax Income | -15,598 | -8,920 | -10,380 | -12,612 | -23,333 |
| Net Income Continuous | -15,598 | -8,920 | -10,380 | -12,612 | -23,333 |
| Net Income | $-15,598 | $-8,920 | $-10,380 | $-12,612 | $-23,333 |
| EPS Basic Total Ops | -0.36 | -0.21 | -0.26 | -0.34 | -0.66 |
| EPS Basic Continuous Ops | -0.36 | -0.21 | -0.26 | -0.34 | -0.66 |
| EPS Diluted Total Ops | -0.36 | -0.21 | -0.26 | -0.34 | -0.66 |
| EPS Diluted Continuous Ops | -0.36 | -0.21 | -0.26 | -0.34 | -0.66 |
| EPS Diluted Before Non-Recurring Items | -0.19 | -0.21 | N/A | N/A | N/A |
| EBITDA(a) | $-14,614 | $-7,860 | $-9,377 | $-11,443 | $-22,652 |